Rigel Pharmaceuticals | RIGL - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agenus USD 128M 21M 2026-03
Amgen USD 195.44B 5.55B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Celldex Therapeutics USD 2.92B 809M 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
MacroGenics USD 184M 82M 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Veracyte USD 4.69B 2.12B 2026-06